Why Biotech Disruptor Ginkgo Bioworks Is Well-Positioned for the Future Lab worker testing laboratory · Motley Fool Micah Angel, The Motley Fool August 5, 2022 4 min read ZY Beaten down from its highs late last year, cell engineering company Ginkgo Bioworks now looks primed to divide and conquer. Continue Reading Terms and Privacy Policy Privacy Dashboard More Info